Computational Biology Market to Exhibit Growth at 21.30% CAGR from 2012

Transparency Market Research Computational Biology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018

Published Date 07-May-2013

112 Page Report

Buy Now

Request Sample

Press Release

Global Computational Biology Market to Register a 21.30% CAGR till 2018 due to Increased Investment in New Methods of Drug Discovery

Transparency Market Research State Tower, 90, State Street, Suite 700.

Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com

Computational Biology Market

REPORT DESCRIPTION

Computational Biology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018 Transparency Market Research’s new market report, titled ‘Computational Biology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018’, provides a comprehensive analysis of the computational biology market on the basis of application, tools, and services.

This report studies the global computational biology market for through the perspective of disease modeling and cellular modeling. It shows how computers are widely being used for examining the mechanism and various processes of cell biology.

Computational biology is a field of science that is critically used in the healthcare industry. Many biotechnology and pharmaceutical companies use computational biology to reduce the incidence of late stage failures of drugs and curb the research and development costs.

Browse Full Report with TOC: http://www.transparencymarketresearch.com/computational-biology.html The computational biology market is predicted to have a notable growth owing to its wide use by biotechnology and pharmaceutical companies to reduce the incidences of late stage failures of their drugs and thereby curb R&D expenditure. This market involves application of biology and information technology field for drug discovery and drug development. Computational biology also assists in reducing extensive use of human in clinical trials and is therefore useful for pediatric trials, trials on pregnant women and orphan disease research.

The computational biology market has witnessed significant growth in the past due to rise in late stage drug failure coupled with its ability to reduce extensive use of humans in clinical trials.

This report provides an in-depth and comprehensive analysis of the computational biology market on the basis of application, tools and by services. This report studies the global market for computational biology through the perspective of cellular modeling and disease modeling. In application segment, the report covers cellular & biological simulation and disease modeling and simulation application or CADD (Computer Aided Drug Design). Cellular & biological simulation market has also been segmented on the basis of computational genomics, computational proteomics, pharmacogenomics and others (transcriptomics/ metabolomics). Disease modeling and simulation segment is categorized into drug discovery and drug development. The market of drug discovery is divided into target identification, target validation, lead discovery and lead optimization. Drug

Computational Biology Market

development market is segmented as preclinical, clinical trials and human body simulation software. The market of clinical trials is studies based on phase I, phase II and phase III trials.

Enquiry Before Buying: http://www.transparencymarketresearch.com/sample/sample.php? flag=S&rep_id=1120 The market of computational biology market, by tools is categorized into database, IT infrastructure (hardware) and analysis software and services types. The computational biology services market highlights the trend of inhouse computational biology and external or contract computational biology. The report also provides various types of technological advancements taking place in each segment. All the above mentioned segments are analyzed on the basis of market size in terms of USD million and their forecasts for the period 2012 to 2018 have also been provided. The CAGR (%) for each market segment has been estimated for the forecast period 2012 to 2018, considering 2011 as the base year. In addition, this report covers participation of different organizations of the U.S. and the U.K. for the development of computational biology market.

The market is also forecasted in terms of value (USD million) for the period 2012 – 2018 for four major geographic regions, namely North America, Europe, Asia-Pacific and Rest of the World (RoW). Market sizes, forecasts and % CAGR for each region have been provided in geography segment. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the computational biology market and future opportunities are covered in the report. Moreover, a PESTLE analysis has been done while estimating individual geographies in order to provide current as well as future status. A list of recommendations for existing as well as new entrants has been discussed in the study. This recommendation chapter provides assistance to industry players on ways to enter this market or to establish sustainable competitive advantage.

Some of the key market players of the global computational biology market include Genedata AG, Nimbus Discovery LLC, Rhenovia Pharma SAS, Certara, Chemical Computing Group, Inc., Compugen, Ltd, Simulation Plus, Inc., Schrodinger, Leadscope, Inc., Accelrys, Entelos and Insilico Biotechnology AG. Market players are profiled in this report on the basis of attributes such as company overview, financial overview, business strategies adopted by the companies to ensure sustainability and maximize profits, product portfolio and recent developments. The competitive landscape of this industry has been covered under market share analysis by key players.

Browse Full Press Release @http://www.transparencymarketresearch.com/pressrelease/computationalbiology.htm

Computational Biology Market

TABLE OF CONTENT

Chapter 1 Introduction 1.1 Report Description 1.2 Market Segmentation 1.3 Scope Of The Report 1.4 Research Methodology 1.4.1 Sources 1.4.1.1 Secondary Research 1.4.1.2 Primary Research 1.4.1.3 Models 1.5 Assumptions

Chapter 2 Executive Summary 2.1 Market Snapshot: Global Computational Biology Market (2011 & 2018) 2.2 Global Computational Biology Market, by Types, 2011 (USD Million)

Chapter 3 Global Computational Biology Market Dynamics 3.1 Market Overview 3.2 Drivers 3.2.1 Failure Of Drug Candidates in Late Stage of Clinical Trials 3.2.1.1 Average Cost to Develop One New Drug (1975 -2011) (USD Million) 3.2.1.2 Trend of Rise in Failure of Phase II Clinical Trials (2006- 2012) 3.2.1.3 Reasons For Failure (%) in Phase II & Phase III 3.2.2 Enhanced Computational Tools 3.2.3 Improved Government Funding &Industrial Support

Computational Biology Market

3.3 Restraints 3.3.1 Lack of Standardization 3.3.2 Non-Verified Predictive Models 3.4 Challenges 3.4.1 Shortage of Skilled Resources 3.4.2 Data Storage 3.5 Opportunities 3.5.1 Cloud Computing 3.5.2 Modelling And Simulations in Paediatrics Drug Development 3.6 Porters Five Forces Analysis 3.6.1 Bargaining Power of Suppliers 3.6.2 Bargaining Power of Buyers 3.6.3 Threat of New Entrants 3.6.4 Threat Of Substitutes 3.6.5 Competitive Rivalry 3.7 Market Attractiveness Analysis 3.7.1 Market Attractiveness Analysis: Global Computational Biology Market, by Geography 3.8 End User Analysis 3.8.1 End User Analysis: Global Computational Biology Market, 2011 & 2018 (%)

Chapter 4 Global Computational Biology Market, by Applications 4.1 Introduction 4.1.1 Cellular Modelling and Simulation 4.1.1.1 Computational Genomics 4.1.1.1.1 Global Computational Genomics Market Revenues, 2010 – 2018 (USD Million) 4.1.1.2 Computational Proteomics

Computational Biology Market

4.1.1.2.1 Global Computational Proteomics Market Revenues, 2010 – 2018 (USD Million) 4.1.1.3 Pharmacogenomics 4.1.1.3.1 Global Computational Pharmacogenomics Market Revenues, 2010 – 2018 (USD Million) 4.1.1.4 Others (Metabolomics/ Transcriptomics) 4.1.1.4.1 Global Computational Others (Metabolomics/Transcriptomics) Market Revenue, 2010 – 2018 (USD Million) 4.1.2 Disease Modelling And Simulation Applications / CADD (Computer Aided Drug Design) 4.1.2.1 Drug Discovery 4.1.2.1.1 Global Computational Drug Discovery Market Revenues, 2010 – 2018 (USD Million) 4.1.2.1.2 Target Identification 4.1.2.1.2.1 Global Computational Target Identification Market Revenues, 2010 – 2018 (USD Million) 4.1.2.1.3 Target Validation 4.1.2.1.3.1 Global Computational Target Validation Market Revenues, 2010 – 2018 (USD Million) 4.1.2.1.4 Lead Identification/Discovery 4.1.2.1.4.1 Global Computational Lead Identification Market Revenues, 2010 – 2018 (USD Million) 4.1.2.1.5 Lead Optimization 4.1.2.1.5.1 Global Computational Lead Optimization Market Revenues, 2010 – 2018 (USD Million) 4.1.2.1 Drug Development 4.1.2.1.1 Preclinical 4.1.2.1.1.1 Global Computational Preclinical Trials Market Revenues, 2010 – 2018 (USD Million) 4.1.2.1.2 Clinical Trials 4.1.2.1.2.1 Global Computational Clinical Trials Market Revenues, 2010 – 2018 (USD Million)

Computational Biology Market

4.1.2.1.2.2 Phase I 4.1.2.1.2.3 Global Computational Clinical Trials Phase I Market Revenues, 2010 – 2018 (USD Million) 4.1.2.1.2.4 Phase II 4.1.2.1.2.5 Global Computational Clinical Trials Phase II Market Revenues, 2010 – 2018 (USD Million) 4.1.2.1.2.6 Phase III 4.1.2.1.2.7 Global Computational Clinical Trials Phase III Market Revenues, 2010 – 2018 (USD Million) 4.1.2.1.3 Human Body Simulation Software 4.1.2.1.3.1 Global Computational Human Simulation Software Market Revenues, 2010 – 2018 (USD Million)

Chapter 5 Global Computational Biology Market, by Tools 5.1 Overview 5.2 Database 5.2.1 Global Computational Biology Database Market Revenues, 2010 – 2018 (USD Million) 5.3 IT Infrastructure (Hardware) 5.3.1 Global Computational Biology Hardware Market Revenues, 2010 – 2018 (USD Million) 5.4 Analysis Software & Services 5.4.1 Global Computational Biology Software Market Revenues, 2010 – 2018 (USD Million)

Chapter 6 Global Computational Biology Market, by Services 6.1 Overview 6.2 In-House Computational Biology 6.2.1 Global In-House Computational Biology Market Revenues, 2010 – 2018 (USD Million) 6.3 External/Contract Computational Biology

Computational Biology Market

6.3.1 Global Contract Computational Biology Market Revenues, 2010 – 2018 (USD Million)

Chapter 7 Global Computational Biology Market, by Geography 7.1 Overview 7.2 North America 7.2.1 North America Computational Biology Market Revenues, 2010 – 2018 (USD Million) 7.3 Europe 7.3.1 Europe Computational Biology Market Revenues, 2010 – 2018 (USD Million) 7.4 Asia 7.4.1 Asia Computational Biology Market Revenues, 2010 – 2018 (USD Million) 7.5 ROW 7.5.1 Row Computational Biology Market Revenues, 2010 – 2018 (USD Million)

Chapter 8 Market Share Analysis 8.1 Market Share by Key Players 8.1.1 Global Computational Biology Market Share Analysis of Key Players, 2011 (%)

Chapter 9 Recommendations 9.1 Success Strategies 9.1.1 Rigorous Research and Development (R&D) Initiatives 9.1.2 Investing in Emerging Economies 9.1.3 Investing in High-End Technologies 9.1.4 Collaborations, Mergers and Acquisitions 9.2 Barriers to be Considered 9.2.1 High Cost of Investment

Computational Biology Market

Chapter 10 Company Profiles 10.1 Accelrys 10.1.1 Company Overview 10.1.2 Financial Overview 10.1.3 Product Portfolio And Services 10.1.4 Business Strategy 10.1.5 Recent Developments 10.2 Certara 10.2.1 Company Profile 10.2.2 Financial Overview 10.2.3 Product Portfolio And Services 10.2.4 Business Strategy 10.2.5 Recent Developments 10.3 Chemical Computing Group Inc. 10.3.1 Company Profile 10.3.2 Financial Overview 10.3.3 Product Portfolio 10.3.4 Business Strategy 10.3.5 Recent Developments 10.4 Compugen, Ltd 10.4.1 Company Profile 10.4.2 Financial Overview 10.4.3 Business Strategy 10.4.4 Recent Developments 10.5 Entelos 10.5.1 Company Profile

Computational Biology Market

10.5.2 Financial Overview 10.5.3 Product Portfolio And Services 10.5.4 Business Strategy 10.5.5 Recent Developments 10.6 Genedata AG 10.6.1 Company Profile 10.6.2 Financial Overview 10.6.3 Product Portfolio And Services 10.6.4 Business Strategy 10.6.5 Recent Developments 10.7 Insilico Biotechnology AG 10.7.1 Company Profile 10.7.2 Financial Overview 10.7.3 Product Portfolio 10.7.4 Business Strategy 10.7.5 Recent Developments 10.8 Leadscope, Inc 10.8.1 Company Profile 10.8.2 Financial Overview 10.8.3 Product Portfolio 10.8.4 Business Strategy 10.8.5 Recent Developments 10.9 Nimbus Discovery LLC 10.9.1 Company Profile 10.9.2 Financial Overview 10.9.3 Product Portfolio

Computational Biology Market

10.9.4 Business Strategy 10.9.5 Recent Developments 10.10 Rhenovia Pharma SAS 10.10.1 Company Profile 10.10.2 Financial Overview 10.10.3 Product Portfolio And Services 10.10.4 Business Startegy 10.10.5 Recent Developments 10.11 Schrodinger 10.11.1 Company Overview 10.11.2 Financial Overview 10.11.3 Product Portfolio And Services 10.11.4 Business Strategy 10.11.5 Recent Developments 10.12 Simulation Plus, Inc. 10.12.1 Company Profile 10.12.2 Financial Overview 10.12.3 Product Portfolio And Services 10.12.4 Business Strategy 10.12.5 Recent Developments

Computational Biology Market

About Us

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact

Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/